Global Biosimilar Drug Sales Market Report 2017

January 2017 | 121 pages | ID: G8359A2DABFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Biosimilar Drug

Revenue, means the sales value of Biosimilar Drug

This report studies sales (consumption) of Biosimilar Drug in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• CP Guojian Pharma
• Biotech Pharma
• Celgen Pharma
• Henlius

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Biosimilar Drug in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Injection
• Tablets
• Others

Split by applications, this report focuses on sales, market share and growth rate of Biosimilar Drug in each application, can be divided into

• Ankylosing Spondylitis
• Tumor
• Rheumatoid Arthrtis
• Cardiovascular

Contents

Global Biosimilar Drug Sales Market Report 2017

1 BIOSIMILAR DRUG OVERVIEW

1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug
  1.2.1 Injection
  1.2.2 Tablets
  1.2.3 Others
1.3 Application of Biosimilar Drug
  1.3.1 Ankylosing Spondylitis
  1.3.2 Tumor
  1.3.3 Rheumatoid Arthrtis
  1.3.4 Cardiovascular
1.4 Biosimilar Drug Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Biosimilar Drug (2012-2022)
  1.5.1 Global Biosimilar Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Biosimilar Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL BIOSIMILAR DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Biosimilar Drug Market Competition by Manufacturers
  2.1.1 Global Biosimilar Drug Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Biosimilar Drug Revenue and Share by Manufacturers (2012-2017)
2.2 Global Biosimilar Drug (Volume and Value) by Type
  2.2.1 Global Biosimilar Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Global Biosimilar Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Biosimilar Drug (Volume and Value) by Regions
  2.3.1 Global Biosimilar Drug Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Biosimilar Drug Revenue and Market Share by Regions (2012-2017)
2.4 Global Biosimilar Drug (Volume) by Application

3 UNITED STATES BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Biosimilar Drug Sales and Value (2012-2017)
  3.1.1 United States Biosimilar Drug Sales and Growth Rate (2012-2017)
  3.1.2 United States Biosimilar Drug Revenue and Growth Rate (2012-2017)
  3.1.3 United States Biosimilar Drug Sales Price Trend (2012-2017)
3.2 United States Biosimilar Drug Sales and Market Share by Manufacturers
3.3 United States Biosimilar Drug Sales and Market Share by Type
3.4 United States Biosimilar Drug Sales and Market Share by Application

4 CHINA BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Biosimilar Drug Sales and Value (2012-2017)
  4.1.1 China Biosimilar Drug Sales and Growth Rate (2012-2017)
  4.1.2 China Biosimilar Drug Revenue and Growth Rate (2012-2017)
  4.1.3 China Biosimilar Drug Sales Price Trend (2012-2017)
4.2 China Biosimilar Drug Sales and Market Share by Manufacturers
4.3 China Biosimilar Drug Sales and Market Share by Type
4.4 China Biosimilar Drug Sales and Market Share by Application

5 EUROPE BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Biosimilar Drug Sales and Value (2012-2017)
  5.1.1 Europe Biosimilar Drug Sales and Growth Rate (2012-2017)
  5.1.2 Europe Biosimilar Drug Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Biosimilar Drug Sales Price Trend (2012-2017)
5.2 Europe Biosimilar Drug Sales and Market Share by Manufacturers
5.3 Europe Biosimilar Drug Sales and Market Share by Type
5.4 Europe Biosimilar Drug Sales and Market Share by Application

6 JAPAN BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Biosimilar Drug Sales and Value (2012-2017)
  6.1.1 Japan Biosimilar Drug Sales and Growth Rate (2012-2017)
  6.1.2 Japan Biosimilar Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Biosimilar Drug Sales Price Trend (2012-2017)
6.2 Japan Biosimilar Drug Sales and Market Share by Manufacturers
6.3 Japan Biosimilar Drug Sales and Market Share by Type
6.4 Japan Biosimilar Drug Sales and Market Share by Application

7 SOUTHEAST ASIA BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Biosimilar Drug Sales and Value (2012-2017)
  7.1.1 Southeast Asia Biosimilar Drug Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Biosimilar Drug Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Biosimilar Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Biosimilar Drug Sales and Market Share by Manufacturers
7.3 Southeast Asia Biosimilar Drug Sales and Market Share by Type
7.4 Southeast Asia Biosimilar Drug Sales and Market Share by Application

8 INDIA BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Biosimilar Drug Sales and Value (2012-2017)
  8.1.1 India Biosimilar Drug Sales and Growth Rate (2012-2017)
  8.1.2 India Biosimilar Drug Revenue and Growth Rate (2012-2017)
  8.1.3 India Biosimilar Drug Sales Price Trend (2012-2017)
8.2 India Biosimilar Drug Sales and Market Share by Manufacturers
8.3 India Biosimilar Drug Sales and Market Share by Type
8.4 India Biosimilar Drug Sales and Market Share by Application

9 GLOBAL BIOSIMILAR DRUG MANUFACTURERS ANALYSIS

9.1 CP Guojian Pharma
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Biosimilar Drug Product Type, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Biotech Pharma
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Biosimilar Drug Product Type, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Celgen Pharma
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Biosimilar Drug Product Type, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Henlius
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Biosimilar Drug Product Type, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview

10 BIOSIMILAR DRUG MAUFACTURING COST ANALYSIS

10.1 Biosimilar Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Biosimilar Drug
10.3 Manufacturing Process Analysis of Biosimilar Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Biosimilar Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BIOSIMILAR DRUG MARKET FORECAST (2017-2022)

14.1 Global Biosimilar Drug Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Biosimilar Drug Price and Trend Forecast (2017-2022)
14.2 Global Biosimilar Drug Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Biosimilar Drug Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Biosimilar Drug Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure Global Sales Market Share of Biosimilar Drug by Type in 2015
Figure Injection Picture
Figure Tablets Picture
Figure Others Picture
Table Applications of Biosimilar Drug
Figure Global Sales Market Share of Biosimilar Drug by Application in 2015
Figure Ankylosing Spondylitis Examples
Figure Tumor Examples
Figure Rheumatoid Arthrtis Examples
Figure Cardiovascular Examples
Figure United States Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure China Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Japan Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure India Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Global Biosimilar Drug Sales and Growth Rate (2012-2022)
Figure Global Biosimilar Drug Revenue and Growth Rate (2012-2022)
Table Global Biosimilar Drug Sales of Key Manufacturers (2012-2017)
Table Global Biosimilar Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Biosimilar Drug Sales Share by Manufacturers
Figure 2016 Biosimilar Drug Sales Share by Manufacturers
Table Global Biosimilar Drug Revenue by Manufacturers (2012-2017)
Table Global Biosimilar Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Biosimilar Drug Revenue Share by Manufacturers
Table 2016 Global Biosimilar Drug Revenue Share by Manufacturers
Table Global Biosimilar Drug Sales and Market Share by Type (2012-2017)
Table Global Biosimilar Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Type (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Type (2012-2017)
Table Global Biosimilar Drug Revenue and Market Share by Type (2012-2017)
Table Global Biosimilar Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar Drug by Type (2012-2017)
Figure Global Biosimilar Drug Revenue Growth Rate by Type (2012-2017)
Table Global Biosimilar Drug Sales and Market Share by Regions (2012-2017)
Table Global Biosimilar Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Regions (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Regions (2012-2017)
Table Global Biosimilar Drug Revenue and Market Share by Regions (2012-2017)
Table Global Biosimilar Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Biosimilar Drug by Regions (2012-2017)
Figure Global Biosimilar Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Biosimilar Drug Sales and Market Share by Application (2012-2017)
Table Global Biosimilar Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Application (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Application (2012-2017)
Figure United States Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure United States Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure United States Biosimilar Drug Sales Price Trend (2012-2017)
Table United States Biosimilar Drug Sales by Manufacturers (2012-2017)
Table United States Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table United States Biosimilar Drug Sales by Type (2012-2017)
Table United States Biosimilar Drug Market Share by Type (2012-2017)
Table United States Biosimilar Drug Sales by Application (2012-2017)
Table United States Biosimilar Drug Market Share by Application (2012-2017)
Figure China Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure China Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure China Biosimilar Drug Sales Price Trend (2012-2017)
Table China Biosimilar Drug Sales by Manufacturers (2012-2017)
Table China Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table China Biosimilar Drug Sales by Type (2012-2017)
Table China Biosimilar Drug Market Share by Type (2012-2017)
Table China Biosimilar Drug Sales by Application (2012-2017)
Table China Biosimilar Drug Market Share by Application (2012-2017)
Figure Europe Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure Europe Biosimilar Drug Sales Price Trend (2012-2017)
Table Europe Biosimilar Drug Sales by Manufacturers (2012-2017)
Table Europe Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table Europe Biosimilar Drug Sales by Type (2012-2017)
Table Europe Biosimilar Drug Market Share by Type (2012-2017)
Table Europe Biosimilar Drug Sales by Application (2012-2017)
Table Europe Biosimilar Drug Market Share by Application (2012-2017)
Figure Japan Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure Japan Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure Japan Biosimilar Drug Sales Price Trend (2012-2017)
Table Japan Biosimilar Drug Sales by Manufacturers (2012-2017)
Table Japan Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table Japan Biosimilar Drug Sales by Type (2012-2017)
Table Japan Biosimilar Drug Market Share by Type (2012-2017)
Table Japan Biosimilar Drug Sales by Application (2012-2017)
Table Japan Biosimilar Drug Market Share by Application (2012-2017)
Figure Southeast Asia Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Drug Sales Price Trend (2012-2017)
Table Southeast Asia Biosimilar Drug Sales by Manufacturers (2012-2017)
Table Southeast Asia Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table Southeast Asia Biosimilar Drug Sales by Type (2012-2017)
Table Southeast Asia Biosimilar Drug Market Share by Type (2012-2017)
Table Southeast Asia Biosimilar Drug Sales by Application (2012-2017)
Table Southeast Asia Biosimilar Drug Market Share by Application (2012-2017)
Figure India Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure India Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure India Biosimilar Drug Sales Price Trend (2012-2017)
Table India Biosimilar Drug Sales by Manufacturers (2012-2017)
Table India Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table India Biosimilar Drug Sales by Type (2012-2017)
Table India Biosimilar Drug Market Share by Type (2012-2017)
Table India Biosimilar Drug Sales by Application (2012-2017)
Table India Biosimilar Drug Market Share by Application (2012-2017)
Table CP Guojian Pharma Basic Information List
Table CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CP Guojian Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotech Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Celgen Pharma Basic Information List
Table Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgen Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Henlius Basic Information List
Table Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Henlius Biosimilar Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure Global Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Regions (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Type (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Application (2017-2022)